Cancer therapy is limited, in part, by lack of specificity. Thus, identifying molecules that are
selectively expressed by, and relevant for, cancer cells is of paramount medical importance …

FKBP3 is a member of FK506-binding proteins (FKBPs). Little is known about the expression
and functional role (s) of FKBP3 in non-small cell lung cancer (NSCLC). In the present study …

The complexity of lung adenocarcinoma (LUAD), the development of which involves many
interacting biological processes, makes it difficult to find therapeutic biomarkers for …

Objective. To study the expression, biological function, and mechanism of FKBP4 in non‐
small‐cell lung cancer (NSCLC). Methods. First of all, the expression of FKBP4 in NSCLC …

Lung cancer is one of the most prevalent cancer types worldwide, and non‑small‑cell lung
cancer (NSCLC) accounts for~ 85% of all lung cancer cases. Despite the notable …

FKBP10, a member of the FK506-binding protein (FKBP) family, has been implicated in
cancer development, although its prognostic function remains controversial. In this study, we …

Background Although the availability of therapeutic options including temozolomide,
radiotherapy and some target agents following neurosurgery, the prognosis of glioma …

We have recently shown that the immunophilin FKBP5 (also known as FKBP51) is a
scaffolding protein that can enhance PHLPP-AKT interaction and facilitate PHLPP-mediated …

Abstract Liver kinase B1 (LKB1) regulates both cell growth and energy metabolism.
Inactivated mutations of LKB1, observed in 20–30% of nonsmall cell lung cancers (NSCLC) …

Background FK506 binding proteins (FKBP) are multifunctional proteins highly conserved
across the species and abundantly expressed in the cell. In addition to a well-established …